ClearTape

Company stock · NYSE · USD

PFE

Pfizer Inc

$30.03

Today

−$0.39-1.28%

vs yesterday’s close

Live price

Opened at
$30.28
Day high
$30.32
Day low
$29.81
Yesterday’s close
$30.42
Sector
Healthcare
Industry
Pharmaceuticals
Size
Large company
Market value
$171.2 billion
Number of shares
5.70 billion
Country
US
Went public
Jan 17, 1944
Exchange
NYSE
Website
pfizer.com
Next earnings
2026-11-03 · analysts’ expected profit per share $0.74

Price chart Pro

Loading chart…

Loading chart…

Company briefing

What PFE is

Plain English context — why the name shows up in the news, and what to watch next.

In plain English

Pfizer Inc. develops and sells prescription medicines and vaccines, including a new 25‑valent pneumococcal conjugate vaccine for infants…

Latest on this name

Insights & deeper context

8 recent cards — open any for the full deeper dive.

CompanyShort-termNeutralDays to weeksBenzingaMRNAPFEMRK 

A New War on Cancer? NIH's Vaccine Initiative Sparks Biotech Stock Rally

NIH’s cancer vaccine initiative is boosting biotech stocks as investors bet on faster, mRNA‑based cancer therapies.

Benzinga
CompanyShort-termNeutralDays to weeksBenzingaPFEMRNAMRK 

Moderna Stock Cools Off After-Hours, Following Massive 177% Cancer Vaccine Rally — Merck, Pfizer and BioNTech Among mRNA Names Trending Tonight

Positive Phase 3 cancer trial data for intismeran led to a sharp intraday rally in mRNA stocks, but after‑hours trading saw a pullback as investors took profits or reassessed upside.

Benzinga
CompanyShort-termNeutralDays to weeksBenzingaPFEMRNAMRKBNTX 

Merck Just Raised the Stakes for Pfizer's Cancer Vaccine Ambitions

Merck’s new commitment to mRNA cancer vaccines raises the stakes for Pfizer’s oncology ambitions, potentially reshaping the competitive dynamics of the mRNA‑oncology market.

Benzinga
CompanyShort-termUpbeatDays to weeksBenzingaPFEMRNAMRKBNTX 

Pfizer Stock Rises Wednesday: What's Going On?

Pfizer’s stock gains reflect growing confidence in mRNA cancer treatments after Merck and Moderna’s breakthrough melanoma trial.

Benzinga
CompanyBothNeutralMonths+BenzingaMRKBMY 

Big Pharma's Future Growth Rests on Chinese Science? Expert Says: 'We Can't Ban Our Way Out of This'

China's rise in biotech threatens the US's competitive edge and access to new cancer drugs.

Benzinga
CompanyBothNeutralDays to weeksBenzinga 

Kathy Hochul Slams Trump Over Medicare Cut, Says 1.3 Million New Yorkers Will Pay More for Prescriptions: 'A New Assault on Seniors...'

President Trump's decision to end Medicare subsidies will raise prescription drug costs for 1.3 million New Yorkers.

Benzinga
EconomyBothUpbeatDays to weeksBenzingaCATMCDDISPFELLYSNDK 

Dow Jumps Over 900 Points As Crude Oil Falls: Investor Sentiment Improves Further, Fear Index Moves To ‘Greed’ Zone

The Dow Jones' record high and the Fear and Greed index's shift into the 'Greed' zone indicate a significant improvement in investor sentiment.

Benzinga
EconomyBothNeutralDays to weeksBenzingaPFEAMDCATMMYTCNH 

Dow Closes at Record High, Nasdaq Surges 2%, but Fear & Greed Index Signals Investors Are Still Playing It Safe

The market's positive trend and improving sentiment are tempered by the Fear and Greed index's neutral reading, indicating investors are still cautious.

Benzinga

Company reports

Official filings (US SEC and linked cards)

No filings here yet

Official report cards for PFE will show up here when available.

Broad market indexes (like the S&P 500, a basket of 500 large US companies) are shown through popular funds that track them (for example SPY). Company profile and prices use live market data when available.